Abstract
Bacterial translocation is an important source of pancreas infection in acute pancreatitis. The effect of platelet-activating factor (PAF) in the pathogenesis of acute pancreatitis has been proved in various studies. The aim of this study was to determine whether potent PAF antagonists influence bacterial translocation in acute pancreatitis. Acute pancreatitis was induced in 62 Wistar rats by injection of 2.5% sodium taurocholate into the biliopancreatic duct. The rats treated with PAF factor antagonists received intravenous injection of WEB-2170 (10 mg/kg), lexipafant (5 mg/kg), and BN-52021 (5 mg/kg) 30 minutes before induction of acute pancreatitis. Six hours after induction of acute pancreatitis, bacteriologic cultures and histologic scoring of tissues were performed. There was a statistically significant reduction in bacterial translocation to the mesenteric lymph nodes and liver but not to the pancreas of the rats treated with PAF antagonists. No significant increase in the intestinal bacterial population of any group was found. There were no statistical differences between the pancreatic histologic scores of the groups. PAF antagonists reduced bacterial translocation to distant sites other than the pancreas, preventing the bacterial dissemination that occurs in the early phase of acute pancreatitis and may have beneficial effects on the evolution of this disease.
Similar content being viewed by others
References
Kingsnorth AN. Platelet-activating factor. Stand J Gastroenterol(Suppl) 1996;9:28–31.
Formela LJ, Galloway SW, Kingsnorth, AN. Inflammatory mediators in acute pancreatitis. Br J Surg 1995;82:6–13.
Hietaranta AJ, Aho HJ, Nevalainen TJ. Pancreatic phospholipase A2, in cerulein-induced acute pancreatitis in the rat. Int J Pancreatol 1993;14:261–267.
Andersson BO, Moore EE, Banerjee A. Phospholipase A2 regulates critical inflammatory mediators of multiple organ failure. J Surg Res 1994;56:199–205.
Jancar S, Abdo EE, Sampietre SN, Kwasniewski FH, Coelho AMM, Bonizzia A, Machado MCC. Effect of PAF antagonists on cerulein-induced pancreatitis. J Lipid Mediat Cell Signal 1995;11:41–49.
Formela LJ, Wood LM, Whittaker M, Kingsnorth AN. Amelioration of experimental acute pancreatitis with a potent platelet-activating factor antagonist. Br J Surg 1994;81:1783–1785.
Zhang C, Hsueh W. PAF-induced bowel necrosis. Dig Dis Sci 1991;36:634–640.
Runckel NSF, Moody FG, Smith GS, Rodriguez LE, Larocco MT, Miller TAJ. The role of the gut in the development of sepsis in acute pancreatitis. J Surg Res 1991;51:18–23.
Foitzik T, Fernández-Del-Castilo C, Ferraro MJ, Mithofer K, Ratmer DW, Warshaw AL. Pathogenesis and prevention of early pancreatic infection in experimental acute necrotizing pancreatitis. Ann Surg 1995;222:179–185.
Souza LJ, Sampietre SN, Figueiredo S, Yria Y, Machado MCC, Pinotti HW. Translocação bacteriana na pancreatite aguda. Estudo experimental em ratos. Rev Hosp Clin Fat Med S Paulo 1996;51:116–120.
Schmidt J, Rattner DW, Lewandrowski K, Compton CC, Mandavilli U, Knoefel WT, Warshaw AL. A better model of acute pancreatitis for evaluating therapy. Ann Surg 1992;215:44–56.
Saluja KA, Steer M. Pathophysiology of pancreatitis. Digestion 1999;60:27–33.
Tetta C, Mariano F, Buades J, Ronco C, Wratten ML, Ca-mussi G. Relevance of platelet-activating factor in inflammation and sepsis: Mechanisms and kinetics of removal in extracorporeal treatments. Am J Kidney Dis 1997;30(Suppl 4):S57-S65.
Huang YH, Schäfer-Elinder L, Owman H, Lorentzen JC, Ronnelid J, Frostegard J. Induction of IL-4 by plateletactivating factor. Clin Exp 1mmuno1 1996;106:143–148.
Murphy C, Denham W, Denham DW, Yang J, Carter G, Norman J. Specific pancreatic enzymes activate macrophages: The potential missing link between pancreatic inflammation and systemic illness during acute pancreatitis. In Digestive Disease Week abstracts, vol 1. Orlando, 1999, p A338.
Koltay M, Hosford D, Guinot P, Esanu A, Braquet P. Plateletactivating factor. Drugs 1991;42:9–29.
Konturek SJ, Dembinski PJ, Konturek PJ, Warzecha Z, Ja-worek J, Gustav P, Tomaszewska R, Stachura J. Role of platelet-activating factor in pathogenesis of acute pancreatitis in rats. Gut 1992;33:1268–1274.
Zhou W, Levine BA, Olson MS. Platelet-activating factor: A mediator of pancreatic inflammation during cerulein hyperstimulation. Am J Pathol 1993;142:1504–1512.
Zhou W, Mccollum MO, Levine BA, Olson MS. Role of platelet-activating factor in pancreatitis-associated acute lung injury in the rat. Am J Path01 1992;140:971–979.
Jones WG II, Minei JP, Barber AE, Raybum JL, Fahey TJ III, Shires GT III, Shires GT. Bacterial translocation and intestinal atrophy after thermal injury and burn wound sepsis. Ann Surg 1990;211:399–405.
Schmidt H, Secchi A, WeBmann R, Bach A, Bohrer H, Geb-hard MM, Martin E. Effect of endotoxemia on intestinal villus microcirculation in rats. J Surg Res 1996;61:521–526.
Sirois MG, Jancar S, Braquet P, Plante GE, Sirois P. PAF increases vascular permeability in select tissues: Effect of BN-52021 and L-655.240. Prostaglandins 1988;36:63l-644.
Tavares de Lima W, Kwasniewsky FH, Sirois P, Jancar S. Prostaglandins, leukotrienes and essent. Fatty Acids 1995;52:245–249.
Galloway SW, Kingsnorth AN. Lung injury in the microembolic model of acute pancreatitis and amelioration by lexipafant (BB-882), a platelet-activating factor antagonist. Pancreas 1996;13:140–146.
Ryan CM, Schmidt J, Lewandrowski K, Compton CC, Ratt-ner DW, Warshaw AL, Tompkins RG. Gut macromolecular permeability in pancreatitis correlates with severity of disease in rats. Gastroenterology 1993;104:890–895.
Tarpila E, Nystron PO, Franzén L, Ihse I. Bacterial translocation during acute pancreatitis in rats. Eur J Surg 1993;159:109-l13.
Liu Q, Djuricin G, Rossi H, Bewsey K, Nathan C, Weinstein RA, Prim RA. The effect of lexipafant on bacterial translocanon in acute necrotizing pancreatitis in rats. Am Surg 1999;65:611–616.
Deitch EA, Winterthon J, Li M, Berg R. The gut as a portal of entry for bacteremia. Ann Surg 1987;205:681–692.
Swank GM, Deitch EA. Role of the gut in multiple organ failure: Bacterial translocation and permeability changes. World J Surg 1996;20:411–417.
Abdo EE, Machado MCC, Coelho AMM, Sampietri SN, Leite KRM, Molan AT, Pinotti HW. Efeito do antioxidante n2-mercaptopropionilglicina (2-mpg) na pancreatite aguda experimental. Rev Hosp Clin Fac Med São Paula 1998;53:169–173.
Bussolati B, Mariano F, Montrucchio G, Piccoli G, Camussi G. Modulatory effect of interleukin-10 on the production of platelet-activating factor and superoxide anions by human leukocytes. Immunology 1997;90:440–447.
Andersson R, Wang X, Ihse I. The influence of abdominal sepsis on acute pancreatitis in rats: A study on mortality, permeability, arterial pressure, and intestinal blood flow. Pancreas 1995;11:365–373.
Andersson R, Wang X, Sun Z, Deng X, Soltesz V, Ihse I. Effect of a platelet-activating factor antagonist on pancreatitisassociated gut barrier dysfunction in rats. Pancreas 1998;17:107–119.
Masamune A, Shimosegawa T, Kimura K, Fujita M, Sato A, Koizmni M, Toyota T. Specific induction of adhesion molecules in human vascular endothelial cells by rat experimental pancreatitis-associated ascitic fluids. Pancreas 1999;18:141–150.
Takeyama Y, Nishikawa J, Ueda T, Hori Y, Yamamoto M, Kuroda Y. Involvement of peritoneal macrophage in the induction of cytotoxicity due to apoptosis in ascitic fluid associated with severe acute pancreatitis. J Surg Res 1999;82:163–171.
Author information
Authors and Affiliations
Additional information
Supported by grant 97/02382-3 from the Fundação do Amparo a Pesquisa de São Paul0 (FAPESP).
Rights and permissions
About this article
Cite this article
de Souza, L.J., Sampietre, S.N., Assis, R.S. et al. Effect of platelet-activating factor antagonists (BN-52021, WEB-2170, and BB-882) on bacterial translocation in acute pancreatitis. J Gastrointest Surg 5, 364–370 (2001). https://doi.org/10.1016/S1091-255X(01)80063-9
Issue Date:
DOI: https://doi.org/10.1016/S1091-255X(01)80063-9